A detailed history of Nuveen Asset Management, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,675,062 shares of XERS stock, worth $5.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,675,062
Previous 1,342,612 24.76%
Holding current value
$5.73 Million
Previous $3.02 Million 58.05%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.06 - $2.96 $684,847 - $984,052
332,450 Added 24.76%
1,675,062 $4.77 Million
Q2 2024

Aug 09, 2024

SELL
$1.7 - $2.45 $421,413 - $607,330
-247,890 Reduced 15.59%
1,342,612 $3.02 Million
Q1 2024

May 13, 2024

BUY
$2.04 - $3.22 $2.38 Million - $3.75 Million
1,165,530 Added 274.26%
1,590,502 $3.52 Million
Q4 2023

Feb 14, 2024

SELL
$1.47 - $2.36 $422,955 - $679,031
-287,725 Reduced 40.37%
424,972 $998,000
Q3 2023

Nov 14, 2023

BUY
$1.8 - $2.69 $527,634 - $788,519
293,130 Added 69.86%
712,697 $1.33 Million
Q2 2023

Aug 14, 2023

SELL
$1.82 - $2.98 $3,365 - $5,510
-1,849 Reduced 0.44%
419,567 $1.1 Million
Q1 2023

May 15, 2023

SELL
$1.03 - $1.63 $5,567 - $8,810
-5,405 Reduced 1.27%
421,416 $686,000
Q4 2022

Feb 14, 2023

SELL
$1.14 - $1.65 $26,632 - $38,547
-23,362 Reduced 5.19%
426,821 $567,000
Q3 2022

Nov 14, 2022

BUY
$1.37 - $1.93 $7,204 - $10,149
5,259 Added 1.18%
450,183 $702,000
Q2 2022

Aug 15, 2022

BUY
$1.48 - $2.64 $658,487 - $1.17 Million
444,924 New
444,924 $685,000

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $465M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.